Both in Pharmaceuticals
Biote vs Impact BioMedical
Over the past year BTMD returned −60.4% and IBO returned −40.2%; their daily moves had a correlation of 0.03.
BTMD −60.4% IBO −40.2%Growth of $1, one year, split-adjusted
| Metric | BTMD | IBO |
|---|---|---|
| Price | $1.12 | $4.02 |
| Market cap | $32.1M | $34.3M |
| Today | −0.89% | +0.25% |
| 1 month | 0.0% | −16.9% |
| 6 months | −49.3% | −50.5% |
| Year to date | −56.9% | −36.9% |
| 1 year | −61.0% | −40.5% |
| Revenue growth (YoY) | −9.5% | −57.1% |
| Gross margin | 65.4% | −533.3% |
| Net margin | −14.8% | −23300.0% |
| P/E (TTM) | 5.5× | 43.5× |
| Price / sales | 0.2× | 981.3× |
| Net cash | -$110.3M | $10.0K |
| Dividend yield | — | — |
| Volatility (60d) | 66.7% | 736.6% |
| Short % of float | 5.4% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).